Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
about
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
P2860
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rationale and design of the SY ...... de novo three-vessel disease.
@en
type
label
Rationale and design of the SY ...... de novo three-vessel disease.
@en
prefLabel
Rationale and design of the SY ...... de novo three-vessel disease.
@en
P2093
P50
P356
P1476
Rationale and design of the SY ...... de novo three-vessel disease.
@en
P2093
Arie-Pieter Kappetein
Bojan M Stanetic
Carlos M Campos
David Taggart
Gerrit-Anne van Es
Javier Escaned
Marie-Angèle Morel
Mauro Echavarria-Pinto
Nicola Ryan
Pannipa Suwannasom
P304
P356
10.4244/EIJV12I2A36
P577
2016-06-01T00:00:00Z